LeMaitre Vascular, Inc. (LMAT) Social Stream
LEMAITRE VASCULAR INC (LMAT) Price Targets From Analysts
Use the tables below to see what analysts covering LEMAITRE VASCULAR INC think about its future price and what recommendations they have for investors and traders.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Current Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2021-11-04 | 5 | $70 | $58 | $62.5 | $55.19 | 13.25% |
| 2022-01-06 | 5 | $70.001 | $58 | $62.5 | $55.19 | 13.25% |
| 2022-01-21 | 4 | $70.001 | $48 | $59.5 | $55.19 | 7.81% |
| 2022-02-24 | 5 | $65 | $48 | $58.25 | $55.19 | 5.54% |
| 2022-02-25 | 5 | $65 | $48 | $56.25 | $55.19 | 1.92% |
| 2022-04-28 | 5 | $65 | $48 | $53.75 | $55.19 | -2.61% |
| 2022-05-01 | 5 | $65 | $48 | $52.75 | $55.19 | -4.42% |
| 2022-07-29 | 5 | $65 | $45 | $52 | $55.19 | -5.78% |
| 2022-08-03 | 5 | $65 | $48 | $53.25 | $55.19 | -3.52% |
| 2022-09-15 | 5 | $65 | $48 | $54 | $55.19 | -2.16% |
| 2022-10-12 | 5 | $56 | $48 | $51.75 | $55.19 | -6.23% |
| 2022-10-27 | 5 | $56 | $48 | $51.75 | $55.19 | -6.23% |
| 2022-11-07 | 4 | $56 | $46 | $50.75 | $55.19 | -8.04% |
| 2023-02-23 | 5 | $57 | $46 | $51 | $55.19 | -7.59% |
| 2023-03-07 | 5 | $57 | $48 | $51 | $55.19 | -7.59% |
| 2023-05-03 | 5 | $63 | $48 | $53 | $55.19 | -3.97% |
| 2023-08-01 | 5 | $63 | $54 | $59.75 | $55.19 | 8.26% |
| 2023-08-03 | 6 | $75 | $54 | $64.4 | $55.19 | 16.69% |
| 2023-08-09 | 6 | $75 | $58 | $65.2 | $55.19 | 18.14% |
| 2023-09-06 | 7 | $75 | $58 | $66 | $55.19 | 19.59% |
| 2023-09-21 | 6 | $75 | $58 | $66 | $55.19 | 19.59% |
| 2023-10-23 | 7 | $75 | $58 | $65.142 | $55.19 | 18.03% |
| 2023-11-02 | 7 | $75 | $50 | $61.142 | $55.19 | 10.78% |
The Trend in the Analyst Price Target
LMAT's average price target has moved down $2.27 over the prior 27 months.
Over the past 36 weeks, LMAT's average upside potential has been 12.82%.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Share Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2023-02-23 | 5 | 57 | 46 | 50.333 | 49.18 | 2.34% |
| 2023-05-03 | 5 | 63 | 48 | 53.000 | 63.09 | -15.99% |
| 2023-08-01 | 5 | 63 | 54 | 59.750 | 62.82 | -4.89% |
| 2023-09-06 | 7 | 75 | 58 | 66.000 | 56.65 | 16.5% |
| 2023-11-02 | 6 | 75 | 50 | 61.142 | 46.65 | 31.07% |
LMAT Broker Recommendations Summary
| Average Broker Rating | Strong Buy | Buy | Hold | Sell | Strong Sell | Analysts Issuing Recs |
|---|---|---|---|---|---|---|
| 1.67 | 4 | 0 | 2 | 0 | 0 | 6 |
The Trend in the Broker Recommendations
Over the past 16 months, LMAT's average broker recommendation rating improved by 0.53.
The points below can provide you with additional insight regarding what the price target and recommendations metrics in the table above mean for investors.
- In terms of how LEMAITRE VASCULAR INC fares relative to stocks in the small market cap category, note that its average analyst price target is greater than 2618.07% of that group.
- LEMAITRE VASCULAR INC's upside potential (average analyst target price relative to current price) is higher than 464.32% of stocks in the small market cap category.
- In the context of Healthcare stocks, LEMAITRE VASCULAR INC's variance in analysts' estimates is lower than -448.56% of them.
- In the context of Healthcare stocks, LEMAITRE VASCULAR INC's number of analysts covering the stock is greater than 791.87% of them.
Stocks similar to LEMAITRE VASCULAR INC in the Medical Equipment industry regarding analyst recommendations and price targets are CERS, RVP, and SRDX.
View All Top Stocks by Price Target
Is LMAT a Buy, Hold or Sell? See the POWR Ratings now!